Who Buys Ambulatory Surgery Centers, and at What Multiple?
Last updated
By Axia Growth
In short
Ambulatory surgery centers are a scaled, physician-partnered consolidation category: about 6,400 ASCs treated Medicare fee-for-service patients in 2024. The median ASC transaction multiple reached 7.9x EBITDA in 2025, the highest in at least eight years. National operators such as Tenet's USPI (533 ASCs), Optum's SCA Health, and Ascension, which closed its $3.9 billion AmSurg purchase in 2026, compete with private equity for centers. CMS added 560 surgical procedures to the ASC covered list for 2026, which keeps the outpatient shift running.
What is an Ambulatory Surgery Center business worth?
Ambulatory Surgery Center falls in the Healthcare sector of the Axia Growth sales dataset. For Healthcare businesses in the Under $500K SDE range, the median sale multiple is 3.4x SDE (interquartile range 2.7x-4.2x), based on 182 closed sales, as of 2026-10-28.
ASCs that draw competitive interest tend to share these traits:
A stable group of owner-surgeons with a mix of ages, so case volume does not depend on a few physicians near retirement.
A specialty mix that includes procedures CMS keeps adding to the ASC list, such as orthopedics and total joints.
A commercial payer mix with in-network contracts, not heavy reliance on Medicare rates or out-of-network billing.
Clean revenue cycle performance and a current life-safety and accreditation record.
In certificate-of-need states, a license that would be hard to replicate. North Carolina, for example, now exempts some new ASCs located in a county with more than 125,000 people, which erodes that barrier there.
Physician ownership is shaped by federal fraud-and-abuse rules and state law. The structure of any syndication, buy-in price, or referral pattern is a legal question for counsel, not a market data point. This page does not cite a source for safe-harbor thresholds, and owners should not treat any figure here as advice.
Expect the buyer pool to stay wide over the next 12-24 months, with health systems, payer-owned operators, and PE platforms all active. The FTC divestiture order in the AmSurg deal suggests larger portfolio deals will face more market-by-market review. For a single center, multiples near the 7.9x median depend on physician alignment and case mix more than on headline market growth.
What EBITDA multiple do ambulatory surgery centers sell for?
The median total invested capital-to-EBITDA multiple for ASC transactions ticked up to 7.9 times in 2025, per VMG Health data reported by ASC News. Public buyers cite similar ranges: Tenet has highlighted 8-10 times for initial USPI acquisitions, and Surgery Partners says it has been buying under 8 times adjusted EBITDA. Source: ASC News.
Who are the largest buyers of surgery centers?
Tenet's USPI had interests in 533 ambulatory surgery centers at the end of 2025. Optum's SCA Health cites 340+ ASCs, and Ascension now operates 300 ambulatory surgery centers across 35 states after buying AmSurg. Sources: Ambulatory Surgery Center News; SCA Health; Healthcare Dive.
Do physicians keep ownership when an ASC sells to a national operator?
Usually some, because the model is built on physician partnerships. Surgery Partners describes over 100 employed, 1,000 partnered and 5,000 affiliated physicians. USPI's parent Tenet said it was willing to buy additional interests of up to $250 million from physician owners when it bought SurgCenter Development. Sources: Surgery Partners; Healthcare Dive.
Can ASCs perform total joint replacements for Medicare patients?
Yes. For CY 2020, CMS added Total Knee Arthroplasty to the ASC covered procedures list. For 2026, CMS added 560 surgical procedures and 35 ancillary services to the list and began removing 285 mostly musculoskeletal procedures from the inpatient-only list. Sources: Centers for Medicare & Medicaid Services; Holland & Knight.
Does certificate-of-need law affect ASC deals?
In states that keep CON, it limits new competition and can add value to an existing licensed center. Rules are loosening in places: North Carolina now exempts certain new ASCs located in a county with more than 125,000 people that meet a self-pay and Medicaid revenue test. Source: Holland & Knight.
How much does Medicare pay ASCs compared with hospital outpatient departments?
Less. MedPAC reports the ASC conversion factor ($56.32 in 2026) is less than the factor used in the OPPS ($90.97 in 2026). CMS finalized a 2.6 percent update to ASC payment rates for 2026. Sources: Medicare Payment Advisory Commission (MedPAC); Holland & Knight.
Ambulatory surgery centers are a scaled, physician-partnered consolidation category: about 6,400 ASCs treated Medicare fee-for-service patients in 2024. The median ASC transaction multiple reached 7.9x EBITDA in 2025, the highest in at least eight years. National operators such as Tenet's USPI (533 ASCs), Optum's SCA Health, and Ascension, which closed its $3.9 billion AmSurg purchase in 2026, compete with private equity for centers. CMS added 560 surgical procedures to the ASC covered list for 2026, which keeps the outpatient shift running. ASC M&A in 2026: the median ASC deal multiple hit 7.9x EBITDA in 2025, about 6,400 ASCs bill Medicare, and CMS added 560 procedures to the ASC list for 2026.
When using information from this guide, cite Axia Growth and link to this page.
Axia Growth. Ambulatory Surgery Center M&A. Updated 2026-11-05. https://axiagrowth.com/resources/industries/healthcare/ambulatory-surgery-centers
For buyers
Have a mandate in Ambulatory Surgery Center? Share your buy box.
Axia Growth LLC provides deal origination services and is not a registered broker-dealer, investment adviser, bank, or depository institution. Where Axia's compensation is contingent on closing, it relies on the M&A broker exemption (15 U.S.C. § 78o(b)(13)) and analogous state exemptions, where available. Axia is typically engaged and paid by the acquirer, does not represent sellers, and does not provide, arrange, or receive compensation for transaction financing. See full disclaimer: /legal/disclaimer